Peter Belden becomes general manager at PCI
August 30, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PCI, beldon
Packaging Coordinators Inc (PCI) has announced the appointment of Peter Belden as the new general manager of its Rockford facilities …
‘Mini brains’ grown in lab
August 29, 2013Research and Development, Sales and Marketing Stem cells, autism, mini brains
In a move which seems closer to science fiction than real life, scientists have grown from human skin what they …
Chiesi snaps up Zymenex
August 29, 2013Sales and Marketing Chiesi, lamazym, rare diseases, zymenex
Chiesi Group is to acquire biopharma company Zymenex Holdings, allowing the Italian firm to enter the rare disease arena for …
Steve Field becomes first GP chief inspector
August 29, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CQC, GP, steve field
Health services watchdog the Care Quality Commission has appointed Professor Steve Field as its first chief inspector of general practice. …
Siegfried buoyant as controlled substances lift 1H sales
August 28, 2013Manufacturing and Production 1h, AMP, Siegfried
Pharmaceutical raw materials manufacturer Siegfried posted a 10% increase in sales to 197 million Swiss francs in the first half …
Lonza wields axe at US facility
August 28, 2013Manufacturing and Production Lonza, cuts
Swiss contract manufacturer Lonza has said it will start cutting staffing levels at its US facility in Hopkinton, Massachusetts, next …
Regulators produce QbD report
August 28, 2013Manufacturing and Production, Sales and Marketing EMA, FDA, QbD
European and US regulators have published the first fruits of their collaboration on assessing measures to ensure drugs are manufactured …
‘Inequality’ for Welsh cancer patients
August 28, 2013Sales and Marketing CDF, Cancer, England, NHS, NICE, Wales
Cancer sufferers in England are four times more likely to receive newer treatments on the NHS than patients in Wales, …
PPD appoints David Johnston as executive vice president
August 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PPD, david johnston
Contract research organisation PPD has appointed Dr David Johnston as executive vice president of global laboratory services. Johnston will direct …
FDA warns Fresenius Kabi over plant problems
August 27, 2013Manufacturing and Production FDA, Fresenius, kabi, recall
German drugmaker Fresenius has been sent another warning letter by the US Food and Drug Administration, this time for a …
New ovarian cancer screening shows promise
August 27, 2013Research and Development, Sales and Marketing ovarian cancer, screening
A new screening process for ovarian cancer is showing encouraging results, according to researchers in the US. In a trial …
GSK Crohn’s disease pill fails in Phase III
August 27, 2013Sales and Marketing GSK, vercirnon
A late-stage trial of GlaxoSmithKline’s investigational Crohn’s disease drug failed to benefit patients. The SHIELD-1 study was investigating vercirnon – …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
